A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Dengue viruses (DENV) infect 50 to 100 million people worldwide per year, of which 500,000 develop severe life-threatening disease. This mosquito-borne illness is endemic in most tropical and subtropical countries and has spread significantly over the last decade. While there are several promising v...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Byrd, Chelsea M., Dai, Dongcheng, Grosenbach, Douglas W., Berhanu, Aklile, Jones, Kevin F., Cardwell, Kara B., Schneider, Christine, Wineinger, Kristin A., Page, Jessica M., Harver, Chris, Stavale, Eric, Tyavanagimatt, Shanthakumar, Stone, Melialani A., Bartenschlager, Ralf, Scaturro, Pietro, Hruby, Dennis E., Jordan, Robert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2013
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535982/
https://ncbi.nlm.nih.gov/pubmed/23070172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01429-12
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak